This announcement is a separate document:
シンバイオ製薬：2023年12月期の通期業績予想の修正及び繰延税金資産の取り崩しに関するお知らせ
SymBio Pharmaceuticals: Notice Concerning Revision of Full-Year Earnings Forecasts for the Fiscal Year Ending 2023/12 and Dissolution of Deferred Tax Assets
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.